FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

UCB Minzasolmin Parkinsons Study Misses Endpoints

[ Price : $8.95]

UCB says it is ending the development of minzasolmin, a drug it was working on with Novartis to treat early Parkinsons disease, af...

FDA Alert on Baxter Solution Sets

[ Price : $8.95]

FDA issues an alert against the use of certain Baxter Solution Sets with Duo-Vent Spikes because they were incorrectly assembled w...

ICH M15 Model-Informed Drug Development Principles

[ Price : $8.95]

FDA publishes an International Council for Harmonization draft M15 guidance on model-informed drug development principles.

AMT Designation Program Guidance

[ Price : $8.95]

FDA publishes a guidance with recommendations for participating in the agencys Advanced Manufacturing Technologies Designation Pro...

ICH E11A Pediatric Extrapolation Guidance

[ Price : $8.95]

FDA publishes the International Council on Harmonization E11A Pediatric Extrapolation guidance.

ICH Clinical Practice Guide Annex

[ Price : $8.95]

FDA publishes Annex 2 of the International Council on Harmonization Good Clinical Practice guidance.

Brands International Limits, Delays Inspection: FDA

[ Price : $8.95]

FDA warns a Canadian Brands International facility about limiting and delaying an inspection that also identified CGMP violations.

Sombra Cosmetics CGMP Violations

[ Price : $8.95]

FDA warns Albuquerque, NM-based Sombra Cosmetics about CGMP violations in the manufacturing of finished drugs.

FDA OKs Mesoblasts Ryoncil Cell Therapy

[ Price : $8.95]

FDA approves Mesoblasts Ryoncil to treat some graft-versus-host disease pediatric patients.

Multiple Violations in BD Inspection

[ Price : $8.95]

FDA warns Becton Dickinson about multiple violations at its San Diego facility that manufactures the Pyxis Medication Management S...